Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

F Paneni, JA Beckman, MA Creager… - European heart …, 2013 - academic.oup.com
Hyperglycemia and insulin resistance are key players in the development of atherosclerosis
and its complications. A large body of evidence suggest that metabolic abnormalities cause …

Cellular and molecular mechanisms of endothelial dysfunction in diabetes

AC Roberts, KE Porter - Diabetes and Vascular Disease …, 2013 - journals.sagepub.com
In healthy individuals, the vascular endothelium regulates an intricate balance of factors that
maintain vascular homeostasis and normal arterial function. Functional disruption of the …

Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis

TM Ribeiro-Rodrigues, TL Laundos… - Cardiovascular …, 2017 - academic.oup.com
Aims Myocardial infarction (MI) is the leading cause of morbidity and mortality worldwide
and results from an obstruction in the blood supply to a region of the heart. In an attempt to …

Role of microRNAs in diabetes and its cardiovascular complications

S Shantikumar, A Caporali… - Cardiovascular …, 2012 - academic.oup.com
Diabetes is the most common metabolic disorder and is recognized as one of the most
important health threats of our time. MicroRNAs (miRNAs) are a novel group of non-coding …

Human miR‐221/222 in physiological and atherosclerotic vascular remodeling

DA Chistiakov, IA Sobenin, AN Orekhov… - BioMed research …, 2015 - Wiley Online Library
A cluster of miR‐221/222 is a key player in vascular biology through exhibiting its effects on
vascular smooth muscle cells (VSMCs) and endothelial cells (ECs). These miRNAs …

Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects

I Andreadou, P Efentakis, E Balafas, G Togliatto… - Frontiers in …, 2017 - frontiersin.org
Empagliflozin (EMPA), a drug approved for type 2 diabetes management, reduced
cardiovascular death but is unknown if it reduces myocardial infarction. We sought to …

Adipose mesenchymal stem cells–derived exosomes attenuate retina degeneration of streptozotocin-induced diabetes in rabbits

A Safwat, D Sabry, A Ragiae, E Amer… - Journal of …, 2018 - journals.sagepub.com
This study aimed to evaluate the effect of mesenchymal stem cells (MSCs)–derived
exosomes in retina regeneration of experimentally induced diabetes mellitus (DM) in a …

Urinary microRNA profiling in the nephropathy of type 1 diabetes

C Argyropoulos, K Wang, S McClarty, D Huang… - PloS one, 2013 - journals.plos.org
Background Patients with Type 1 Diabetes (T1D) are particularly vulnerable to development
of Diabetic nephropathy (DN) leading to End Stage Renal Disease. Hence a better …

Endothelial microparticles reduce ICAM‐1 expression in a micro RNA‐222‐dependent mechanism

F Jansen, X Yang, K Baumann… - Journal of cellular …, 2015 - Wiley Online Library
Endothelial microparticles (EMP) are released from activated or apoptotic endothelial cells
(EC s) and can be taken up by adjacent EC s, but their effect on vascular inflammation after …

MicroRNAs: potential mediators and biomarkers of diabetic complications

M Kato, NE Castro, R Natarajan - Free Radical Biology and Medicine, 2013 - Elsevier
The incidence of diabetes is escalating worldwide and, consequently, this has become a
major health care problem. Moreover, both type 1 and type 2 diabetes are associated with …